Table 2. Vital signs and comorbidity of COVID-19 patients.
| all (n=1000) | age<60(n=473) | 60-74(n=359) | age≥75(n=168) | |
| Characteristics on admission | ||||
| Fever, No. (%)a | 200 (21.3%) | 98 (22.1%) | 71 (20.8%) | 31 (20.3%) |
| Temperature | 36.7 (36.4,37.1) | 36.7 (36.4,37.1) | 36.7 (36.5,37.1) | 36.7 (36.5,37) |
| Temperature, No. (%)a | ||||
| < 37.3°C | 739 (78.7%) | 346 (77.9%) | 271 (79.2%) | 122 (79.7%) |
| 37.3-38.0°C | 117 (12.5%) | 55 (12.4%) | 46 (13.5%) | 16 (10.5%) |
| 38.1-39.0°C | 72 (7.7%) | 35 (7.9%) | 23 (6.7%) | 14 (9.2%) |
| ≥ 39.1°C | 11 (1.2%) | 8 (1.8%) | 2 (0.6%) | 1 (0.7%) |
| Heart rate, median (IQR), bpm b | 82 (76,92) | 82(76,92) | 83(76,92) | 80(76,89) |
| Systolic pressure, median (IQR), mmHg c | 126 (116,139) | 123(112,132) | 130(120,142)* | 131(117,148)* |
| Diastolic pressure, median (IQR), mmHg d | 76 (69,83) | 75(68,80) | 76(70,84)* | 76(67,84) |
| Respiratory rate, median (IQR), bpm e | 20 (18,20) | 19(18,20) | 20(18,21)* | 19(18,21) |
| Finger oxygen saturation, median (IQR), % f | 97 (95,99) | 98(96,99) | 97(95,99)* | 96(92,98)*# |
| Characteristics during hospital admission, No. (%) | ||||
| Fever | 623 (66.3%) | 265 (59.7%) | 246 (71.9%)* | 112 (73.2%)* |
| Highest temperature g | ||||
| < 37.3°C | 316 (33.7%) | 179 (40.3%) | 96 (28.1%)* | 41 (26.8%)* |
| 37.3-38.0°C | 352 (37.5%) | 150 (33.8%) | 145 (42.4%)* | 57 (37.3%) |
| 38.1-39.0°C | 203 (21.6%) | 76 (17.1%) | 85 (24.9%)* | 42 (27.5%)* |
| ≥ 39.1°C | 67 (7.1%) | 38 (8.6%) | 16 (4.7%)* | 13 (8.5%) |
| >41.0°C | 1 (0.1%) | 1 (0.2%) | 0 (0%) | 0 (0%) |
| Respiratory rate≥30 bpm | 141 (14.1%) | 45 (9.5%) | 63 (17.5%)* | 33 (19.6%)* |
| Comorbidity, No. (%) | ||||
| Diabetes | 118 (11.8%) | 34 (7.2%) | 55 (15.3%)* | 29 (17.3%)* |
| Hypertension | 282 (28.2%) | 62 (13.1%) | 131 (36.5%)* | 89 (53%)*# |
| Coronary heart disease | 60 (6%) | 6 (1.3%) | 29 (8.1%)* | 25 (14.9%)*# |
| COPD | 23 (2.3%) | 0 (0%) | 17 (4.7%)* | 6 (3.6%)* |
| Asthma | 12 (1.2%) | 3 (0.6%) | 5 (1.4%) | 4 (2.4%) |
| Cerebrovascular disease | 32 (3.2%) | 3 (0.6%) | 8 (2.2%)* | 21 (12.5%)*# |
| Chronic renal disease | 24 (2.4%) | 7 (1.5%) | 7 (1.9%) | 10 (6%)*# |
| Chronic liver disease | 29 (2.9%) | 12 (2.5%) | 12 (3.3%) | 5 (3%) |
| Malignancy | 28 (2.8%) | 7 (1.5%) | 11 (3.1%) | 10 (6%)* |
| Autoimmune disease | 13 (1.3%) | 3 (0.6%) | 6 (1.7%) | 4 (2.4%) |
| Organ transplantation | 2 (0.2%) | 2 (0.4%) | 0 (0%) | 0 (0%) |
| Only one comorbidity | 237 (23.7%) | 67 (14.2%) | 115 (32%)* | 55 (32.7%)* |
| ≥2 comorbidities | 168 (16.8%) | 34 (7.2%) | 75 (20.9%)* | 59 (35.1%)*# |
| With comorbidity | 405 (40.5%) | 101 (21.4%) | 190 (52.9%)* | 114 (67.8%)*# |
The total number of patients with available data: a: n(<60)=444, n(60-74)=342, n(≥75)=153; b: n(<60)=443, n(60-74)=352, n(≥75)=153; c: n(<60)=351, n(60-74)=314, n(≥75)=143; d: n(<60)=354, n(60-74)=314, n(≥75)=143; e: n(<60)=443, n(60-74)=342, n(≥75)=152; f: n(<60)=319, n(60-74)=302, n(≥75)=136; g: n(<60)=444, n(60-74)=342, n(≥75)=153. * p<0.05 vs. <60 group. # p<0.05 vs. 60-74 group.